Medicover secures €450M revolving credit facility
What's the deal? MedicoverDealroom has a profile for this one. Try Dealroom →, the European healthcare and diagnostics company, has signed a €450M revolving credit facility. The deal gives it flexible access to capital to support operations and growth.
Why now? Healthcare companies across Europe are consolidating and expanding, making access to large, flexible credit lines essential. A revolving facility lets Medicover draw and repay funds as needed — useful in a sector where acquisition opportunities can surface quickly.
The signal: Medicover, classified as a late-growth stage company on Dealroom, is reinforcing its balance sheet at a time when European healthcare consolidation is accelerating. Securing a €450M revolving facility — rather than raising equity or issuing fixed debt — suggests the company wants to preserve financial flexibility for opportunistic acquisitions across its sprawling network of clinics, hospitals, and laboratories.
Read more: hk.marketscreener.com
